This means that passive immunization with tau antibodies is usually a practical therapeutic target and that the CSF standard of p-tau262/356 or of your microtubule binding area (MTBD) can function a useful biomarker of tau pathology to monitor tau therapeutics in clinical trials.With this assay, researchers add extracts from Alzheimer’s Mind to c